UK PM Johnson looks set to confirm July 19 lockdown end, with caution

UK Prime Minister Boris Johnson looks set to confirm July 19 as his so-called terminus date for an end to all legal lockdown restrictions in England

Boris Johnson
Press Trust of India London
3 min read Last Updated : Jul 12 2021 | 7:57 PM IST

UK Prime Minister Boris Johnson looks set to confirm July 19 as his so-called terminus date for an end to all legal lockdown restrictions in England, striking a note of caution ahead of the formal announcement on Monday evening.

He is expected to urge the public to remain vigilant as the pandemic is not over and therefore caution will be key in the coming weeks. The move to step 4 in the UK PM's four-step roadmap for an end to lockdown was delayed by four weeks from June 21 to allow every adult to be offered a vaccine.

We are tantalisingly close to the final milestone in our roadmap out of lockdown, but the plan to restore our freedoms must come with a warning, Johnson said in a Downing Street statement ahead of a scheduled briefing on Monday.

While the phenomenal vaccine rollout has offered every adult some protection against the virus, and the crucial link between cases, hospitalisations and deaths is weakened, the global pandemic is not over yet. Cases will rise as we unlock, so as we confirm our plans today, our message will be clear.

"Caution is absolutely vital, and we must all take responsibility so we don't undo our progress, ensuring we continue to protect our NHS, he said.

UK Health Secretary Sajid Javid will update Parliament on the plans from next Monday and lay out that the government's four tests to lift lockdown are being met.

The four tests are that the vaccine deployment programme continues successfully; vaccines are sufficiently effective in reducing hospitalisations and deaths in those vaccinated; infection rates do not risk a surge in hospitalisations which would put unsustainable pressure on the NHS; and the assessment of the risks is not fundamentally changed by new variants of concern (VOCs).

The latest data will be presented, with current modelling suggesting that COVID-19 cases will continue to rise as restrictions are eased. Hospitalisations, serious illness and deaths will also continue, albeit at a much lower level than before the vaccination programme.

As of July 10, Downing Street said a total of 80.3 million vaccine doses have been administered in the UK, with 45.7 million adults receiving a first dose (86.9 per cent) and 34.5 million adults receiving both doses (65.6 per cent).

The government says that reopening from lockdown at a point later in the year may increase pressure on the National Health Service (NHS) because of winter illnesses such as flu.

Analysis from Public Health England (PHE) and the University of Cambridge suggests that vaccines have so far prevented an estimated 8.5 million infections and 30,000 deaths in England alone.

"It is vital that people keep coming forward to get both jabs when called, with data from PHE showing COVID-19 vaccines are highly effective against hospitalisation from the Delta variant. The analysis suggests the Pfizer/BioNTech vaccine is 96 per cent effective and the Oxford/AstraZeneca vaccine is 92 per cent effective against hospitalisation after two doses," Downing Street notes.

Meanwhile, the NHS vaccination rollout is set to continue to accelerate by bringing forward second doses for under 40s to eight weeks.

On Sunday, the UK recorded another 31,772 confirmed coronavirus cases, along with a further 26 deaths.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusBoris JohnsonCoronavirus TestsCoronavirus Vaccine

First Published: Jul 12 2021 | 7:57 PM IST

Next Story